These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16905132)

  • 1. The antinociceptive effect of salvinorin A in mice.
    John TF; French LG; Erlichman JS
    Eur J Pharmacol; 2006 Sep; 545(2-3):129-33. PubMed ID: 16905132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive and hypothermic effects of Salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout mice.
    Ansonoff MA; Zhang J; Czyzyk T; Rothman RB; Stewart J; Xu H; Zjwiony J; Siebert DJ; Yang F; Roth BL; Pintar JE
    J Pharmacol Exp Ther; 2006 Aug; 318(2):641-8. PubMed ID: 16672569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist.
    McCurdy CR; Sufka KJ; Smith GH; Warnick JE; Nieto MJ
    Pharmacol Biochem Behav; 2006 Jan; 83(1):109-13. PubMed ID: 16434091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse.
    Fantegrossi WE; Kugle KM; Valdes LJ; Koreeda M; Woods JH
    Behav Pharmacol; 2005 Dec; 16(8):627-33. PubMed ID: 16286814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinociceptive effect of oxycodone in diabetic mice.
    Nozaki C; Saitoh A; Tamura N; Kamei J
    Eur J Pharmacol; 2005 Nov; 524(1-3):75-9. PubMed ID: 16256106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the antinociceptive effects of oxycodone in diabetic mice.
    Nozaki C; Saitoh A; Kamei J
    Eur J Pharmacol; 2006 Mar; 535(1-3):145-51. PubMed ID: 16533506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice.
    Capasso R; Borrelli F; Zjawiony J; Kutrzeba L; Aviello G; Sarnelli G; Capasso F; Izzo AA
    Neurogastroenterol Motil; 2008 Feb; 20(2):142-8. PubMed ID: 17931335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of kappa-opioid and endocannabinoid system on Salvinorin A-induced reward.
    Braida D; Limonta V; Capurro V; Fadda P; Rubino T; Mascia P; Zani A; Gori E; Fratta W; Parolaro D; Sala M
    Biol Psychiatry; 2008 Feb; 63(3):286-92. PubMed ID: 17920565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
    Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
    J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guinea-pig ileum.
    Capasso R; Borrelli F; Capasso F; Siebert DJ; Stewart DJ; Zjawiony JK; Izzo AA
    Neurogastroenterol Motil; 2006 Jan; 18(1):69-75. PubMed ID: 16371085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
    Chavkin C; Sud S; Jin W; Stewart J; Zjawiony JK; Siebert DJ; Toth BA; Hufeisen SJ; Roth BL
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1197-203. PubMed ID: 14718611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of salvinorin A, a kappa-opioid hallucinogen, on a neuroendocrine biomarker assay in nonhuman primates with high kappa-receptor homology to humans.
    Butelman ER; Mandau M; Tidgewell K; Prisinzano TE; Yuferov V; Kreek MJ
    J Pharmacol Exp Ther; 2007 Jan; 320(1):300-6. PubMed ID: 17060493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
    Roth BL; Baner K; Westkaemper R; Siebert D; Rice KC; Steinberg S; Ernsberger P; Rothman RB
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11934-9. PubMed ID: 12192085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents.
    Braida D; Capurro V; Zani A; Rubino T; Viganò D; Parolaro D; Sala M
    Br J Pharmacol; 2009 Jul; 157(5):844-53. PubMed ID: 19422370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement.
    Braida D; Limonta V; Pegorini S; Zani A; Guerini-Rocco C; Gori E; Sala M
    Psychopharmacology (Berl); 2007 Mar; 190(4):441-8. PubMed ID: 17219220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.
    Cruz A; Domingos S; Gallardo E; Martinho A
    Phytochemistry; 2017 May; 137():9-14. PubMed ID: 28190678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From local to global-fifty years of research on Salvia divinorum.
    Casselman I; Nock CJ; Wohlmuth H; Weatherby RP; Heinrich M
    J Ethnopharmacol; 2014 Feb; 151(2):768-83. PubMed ID: 24315983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys.
    Butelman ER; Harris TJ; Kreek MJ
    Psychopharmacology (Berl); 2004 Mar; 172(2):220-4. PubMed ID: 14586540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.
    Maqueda AE; Valle M; Addy PH; Antonijoan RM; Puntes M; Coimbra J; Ballester MR; Garrido M; González M; Claramunt J; Barker S; Lomnicka I; Waguespack M; Johnson MW; Griffiths RR; Riba J
    Int J Neuropsychopharmacol; 2016 Jul; 19(7):. PubMed ID: 26874330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.